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Abstract
Cyclic nucleotide-sensitive ion channels are molecular pores that open in response to
cAMP or cGMP, which are universal second messengers. Binding of a cyclic nucleotide to
the carboxyterminal cyclic nucleotide binding domain (CNBD) of these channels is thought
to cause a conformational change that promotes channel opening. The C-linker domain,
which connects the channel pore to this CNBD, plays an important role in coupling ligand
binding to channel opening. Current structural insight into this mechanism mainly derives
from X-ray crystal structures of the C-linker/CNBD from hyperpolarization-activated cyclic
nucleotide-modulated (HCN) channels. However, these structures reveal little to no confor-
mational changes upon comparison of the ligand-bound and unbound form. In this study,
we take advantage of a recently identified prokaryote ion channel, SthK, which has function-
al properties that strongly resemble cyclic nucleotide-gated (CNG) channels and is activat-
ed by cAMP, but not by cGMP. We determined X-ray crystal structures of the C-linker/
CNBD of SthK in the presence of cAMP or cGMP. We observe that the structure in complex
with cGMP, which is an antagonist, is similar to previously determined HCN channel struc-
tures. In contrast, the structure in complex with cAMP, which is an agonist, is in a more
open conformation. We observe that the CNBDmakes an outward swinging movement,
which is accompanied by an opening of the C-linker. This conformation mirrors the open
gate structures of the Kv1.2 channel or MthK channel, which suggests that the cAMP-bound
C-linker/CNBD from SthK represents an activated conformation. These results provide a
structural framework for better understanding cyclic nucleotide modulation of ion channels,
including HCN and CNG channels.
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INTRODUCTION
Hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels and cyclic nucleo-
tide-gated (CNG) channels belong to the superfamily of six-transmembrane domain K+ chan-
nels (for reviews, see references [1–4]). HCN channels play an important role in generating
spontaneous rhythmic firing of action potentials in excitable cells and are known targets for a
class of antiarrhythmic agents, including ivabradine [5, 6]. Additionally, mutations in HCN
channel genes are responsible for inherited disorders, such as sinus bradycardia [7]. CNG
channels are important for signal transduction in retinal photoreceptors and olfactory sensory
neurons [3]. Inherited mutations in CNG channel genes are linked to total color blindness [8].
At the molecular level, both HCN and CNG channels have a similar topology and are com-
posed of six transmembrane domains (S1–S6) containing a putative voltage sensor (S4) and a
pore-forming domain (S5–S6), which connects to a cytoplasmic C-linker region and a cyclic
nucleotide-binding domain (CNBD). CNG channels are solely gated by cyclic nucleotides,
cAMP or cGMP, whereas HCN channels are gated by voltage and modulated by cyclic nucleo-
tides. Binding of cyclic nucleotides to the CNBD is thought to cause a conformational change
in the C-linker/CNBD, which opens the channel gate and allows the flux of ions through the
channel pore. The C-linker region, which connects the CNBD to the channel pore, critically
contributes to coupling of ligand binding to channel opening (reviewed in reference [3]).
Current structural insight into the mechanism of channel modulation and ligand specificity
derives from crystal structures of the carboxyterminal C-linker/CNBD of mammalian or inver-
tebrate HCN channels [9–12]. These structures reveal a tetrameric assembly mirroring the
symmetry of the tetrameric channel pore. The tetramer interface of the C-linker/CNBD region
is mainly formed by the C-linker, which is composed of six α-helices, termed αA’ to αF’. At the
subunit interface, the A’-B’ helices from one subunit form an ‘elbow’ resting on the ‘shoulder’
(C’-D’ helices) from a neighboring subunit. Furthermore, previous C-linker/CNBD structures
have shown that the CNBD is composed of a so-called β-roll flanked by two α-helices (A and
B) and a carboxyterminal C-helix, which directly interacts with the ligand. In addition, crystal
structures have also been determined for the C-linker and cyclic nucleotide binding homology
domain (CNBHD) of related ion channels, including the zebrafish EAG-like (ELK) K+ channel
[13], the mosquito ERG K+ channel [14], and the mouse EAG1 K+ channel [15]. Despite this
wealth of structural information, insight into the molecular architecture of the carboxyterminal
region of CNG channels is still lacking. Moreover, all of the HCN channel crystal structures of
the C-linker/CNBD regions determined to date reveal a nearly identical architecture in the ab-
sence and presence of ligand [16], which raises an important question what the conformational
changes are in this region that underlie cyclic nucleotide modulation of HCN and
CNG channels.
In this study, we take advantage of a recently identified prokaryote homologue of HCN and
CNG channels, termed SthK, which originates from the thermophylic bacterium Spirochaeta
thermophila [17]. We previously demonstrated that SthK is gated by cAMP, but not cGMP,
and is relatively insensitive to voltage, which resembles the gating properties of certain eukary-
ote CNG channels (see S1 Fig.). Using X-ray crystallography, we determined the 3-dimensional
structures of the isolated C-linker/CNBD of SthK, termed SthK-Cterm, in complex with cAMP
or cGMP. We observe that the SthK-Cterm structure in complex with cGMP strongly resembles
previously published HCN channel structures. In contrast, in the SthK-Cterm structure in com-
plex with cAMP important differences exist. Here, the C-linker adopts a conformation in
which the A’-helix, which connects to the gate of the channel, is bent and in a more open con-
formation compared to the HCN structures. In addition, we observe that the CNBD undergoes
an outward (i.e. away from the pore axis) swinging motion, which is accompanied by a
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movement of the B- and C-helices. The cAMP-bound SthK-Cterm structure mirrors the open
gate structure of the Kv1.2 channel [18] and MthK channel [19] and suggests that this C-link-
er/CNBD possibly represents an activated conformation. Our results contribute to a better un-
derstanding of the conformational changes that underlie cyclic nucleotide modulation in HCN
and CNG channels.
EXPERIMENTAL PROCEDURES
Protein expression and purification
The DNA fragment encoding amino acid residues 226–430 of the full length sequence was
cloned as a synthetic gene into the NcoI and HindIII restriction sites of pHMalc2T [12],
which is a derivative of pMalc2T (New England Biolabs) containing a hexahistidine tag at the
N-terminus of maltose-binding protein (MBP). This construct was transformed into Escheri-
chia coli BL21(DE3) cells and a cell culture was grown at 37°C in Luria broth to an OD600 nm of
0.6–0.8. Protein expression was induced by addition of 0.4 mM IPTG and the culture was incu-
bated at 18°C overnight. Cells from a 1 L culture were harvested by centrifugation at 10,000 g
and resuspended in 50 mL buffer A, containing 150 mMNaCl, 30 mMHEPES pH 8.0, 5 mM
cAMP, 1 mM DDT and 10% glycerol, supplemented with 1 mM PMSF, 20 mg/mL DNase, 5
mMMgCl2, 1 mg/mL leupeptin, 1 mg/mL pepstatin. Cells were lysed by 2 passes through an
Emulsiflex-C5 high pressure homogenizer (Avestin). The cell lysate was cleared by centrifuga-
tion at 27,000 g for 15 min. The clear supernatant was incubated with 3 mL pre-washed amy-
lose resin (New England Biolabs) for 1–2 hour at 4°C. The resin was collected on a column and
washed with 15 column volumes of buffer A. Bound protein was eluted in 5 column volumes
buffer A supplemented with 50 mMmaltose. Protein concentration was measured by absor-
bance at 280 nm using a Nanodrop 2000 spectrophotometer (Thermo Scientific). Protein was
diluted to a concentration of 3.5 mg/ml and MBP-fusion protein was cleaved with 500 units of
thrombin (Calbiochem) overnight at 4°C. Protein was concentrated on a Amicon ultra filter
device with a molecular weight cut-off of 50,000 Da (Millipore) and loaded on a HiLoad Super-
dex 200 gel filtration column (GE Healthcare) pre-equilibrated with buffer containing 30 mM
HEPES pH 8.0, 500 mMNaCl, 1 mMDTT and 10% glycerol. The tetrameric stoichiometry of
SthK-Cterm was confirmed with a multi-angle laser light system (MALLS) coupled to size exclu-
sion chromatography (shown as S2 Fig.). Fractions corresponding to SthK-Cterm were pooled
and incubated with 1 mL amylose resin for 1 h. Protein was concentrated to 10 mg/mL, snap
frozen in liquid nitrogen and stored at -80°C.
Crystallography
Crystals were grown at 20°C using the sitting-drop vapor diffusion method. cAMP or cGMP
were added to the protein at a final concentration of 3 mM or 5 mM cGMP, respectively. Crys-
tallization screens were set up by mixing 100 nL of the concentrated protein with reservoir so-
lutions at a 1:1 ratio by a Mosquito nanoliter crystallization robot (TTP Labtech). Crystal
growth was monitored using a RockImager (Formulatrix) and for SthK-Cterm in complex with
cAMP a crystallization hit was obtained in the following condition: 100 mMMMT buffer sys-
tem (DL-malic acid, 2-(N-morpholino)ethanesulfonic acid, Tris 1:2:2) pH 5.0 and 25% (w/v)
PEG1500. For SthK-Cterm in complex with cGMP a crystallization hit was obtained in the fol-
lowing condition: 200 mM disodium-malonate, 100 mM bistrispropane pH 7.5 and 20% (w/v)
PEG3350. Crystals were harvested in mother liquor and cryo-protected by the addition of 30%
glycerol in 5% increments. Crystals were flash-cooled by immersion in liquid nitrogen. From
more than 100 crystals tested, a few diffracted X-rays to a resolution better than 2.5Å and dif-
fraction data sets were collected at the X06A beam line of the Swiss Light Source (SLS, Villigen)
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and the ID23–2 beam line of the European Synchrotron Radiation Facility (ESRF, Grenoble).
The structure of SthK-Cterm in complex with cAMP was determined by molecular replacement
with MOLREP using a crystallographic tetramer of the HCN4 carboxyterminal domain (pdb
code 3u11) as a search model, which was first pruned using Chainsaw [20]. The asymmetric
unit contained 2 C-linker/CNBD subunits, termed chain A and chain B. The electron density
map for chain A was of sufficiently high quality to permit building of residues 226 to 423. How-
ever, a small number of side chains in chain A were not built due to poor electron density. The
electron density map for chain B was of notably lower quality and therefore only chain A has
been used for the structure analysis. Initial structure refinement was done with Refmac [20]
and an improved model was obtained using Autobuild in PHENIX [21]. The structure was fur-
ther improved using iterative cycles of manual rebuilding in Coot and automated refinement
in PHENIX [21]. The structure of SthK-Cterm in complex with cGMP was solved by molecular
replacement with the cAMP-bound SthK-Cterm from which the ligand was removed. Structure
validation was done with Molprobity [22] and figures were prepared in Pymol (Schrödinger).
RESULTS
The structures of the SthK C-terminal domain, termed SthK-Cterm, were determined in com-
plex with cAMP or cGMP at 2.6Å resolution. Crystallographic statistics are reported in detail
in Table 1 and crystal packing for the two complexes is shown in S3 Fig. The electron density
map was of sufficiently high quality to permit building of residues 226 to 423. The crystal struc-
ture of SthK-Cterm in complex with cGMP, which is an antagonist, adopts an overall architec-
tural fold that strongly resembles that of previous structures of HCN C-terminal domains. The
root mean square deviation (r.m.s.d.) for the α-carbons of SthK-Cterm and mouse HCN2 in
complex with cGMP (pdb entry 1q3e) is 1.5Å for 184 α-carbons superposed. In contrast, the
structure of SthK-Cterm in complex with cAMP, which is an agonist, displays significant differ-
ences (Fig. 1a-c). Similar to HCN channels, the structure of cAMP-bound SthK-Cterm reveals a
C-linker domain composed of six α-helices (αA’ to αF’), with the A’- and B’-helices forming an
antiparallel helix-turn-helix motif (Fig. 1d). The C-linker domain is followed by the CNBD,
which contains four helices (αA, αB, αP, αC) and eight β-strands arranged in a so-called β-roll,
which is flanked by the A- and B-helices (Fig. 1e). Although the overall fold of the carboxy-
terminal domain of SthK and HCN channels are relatively similar, superposition of the cAMP-
bound structures of SthK and mouse HCN2 reveal significant differences. The r.m.s.d. for
the α-carbons of the two structures is 2.1Å (182 α-carbons superposed), 1.8Å for the C-linker
domain superposed alone (78 α-carbons) and 1.3Å for the CNBD superposed alone (111
α-carbons). For the C-linker domain, the most notable differences are in the N-terminal half of
the A’-helix (Fig. 1d), which connects to the S6 segment of the pore domain, and tilts out- and
upward by a distance of 4Å compared to HCN2. Smaller differences can be seen in the C’-helix
and D’-E’-F’-helices which undergo an outward shift (i.e. away from the pore axis) by less than
2Å. For the CNBD, the β-sheet core of the β-roll is very similar, but most of the differences can
be seen in the B-helix, which tilts outward by a distance of 3–4Å (Fig. 1e).
The SthK-Cterm subunits form a tetramer that radially assembles along a four-fold symme-
try axis that extends to the ion channel pore of the transmembrane domain. The tetramer inter-
face of SthK-Cterm is mainly formed by the C-linker domain, with the ‘elbow’ of one subunit
resting on the ‘shoulder’ of its neighboring subunit (Fig. 1a-c). Superposition of the cAMP-
bound SthK tetramer onto the cGMP-bound SthK tetramer reveals an important change in the
quaternary structure (Fig. 2). The r.m.s.d. for the two structures is 1.8Å for 772 α-carbons su-
perposed, with a clear conformational change of the C-linker domain relative to the CNBD
(Fig. 2a-c). The CNBD makes an outward swinging movement, which is most obvious in the
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P-, B-, and C-helices. This causes a significant widening of the SthK tetramer pore, which is
most pronounced near the CNBD (Fig. 2d-e). In the C-linker domain, the
D’-E’-F’-helices remain relatively constant, whereas the C’-helix makes an outward motion and
the A’-helix undergoes an upward (i.e. toward the membrane side) and outward bending. The
distance measured between the α-carbons of neighboring aminoterminal residues amounts
28.6Å in cAMP-bound SthK compared to 23.8Å in cGMP-bound SthK (indicated as yellow
spheres in Fig. 2a-b). The bigger distance in cAMP-bound SthK mirrors the distance measured
at the carboxyterminal end of the open gate in the structure of the Kv1.2 channel (29.7 Å) and
the MthK channel (30.3Å). This observation suggests that the cAMP-bound structure of
SthK-Cterm represents an activated conformation. In line with recent double electron-electron
resonance data [23], the superposition of cAMP-bound and cGMP-bound SthK-Cterm shows
that there are no conformational differences in the β-roll region from the CNBD upon
cAMP binding. However, significant conformational changes are present in the αP-, αB- and
αC-helix, which make a clear outward movement compared to the cGMP-bound structure
(Fig. 2d-e). A smaller shift can be seen for the αA, αF’ and αE’. The conformational change of
SthK-Cterm upon binding of cAMP is further illustrated with a morphing movie, which is avail-
able as supplementary material.
Table 1.
SthK-Cterm in complex with cAMP SthK-Cterm in complex with cGMP
Crystallographic statistics
Beamline X06A (SLS) ID23–2 (ESRF)
Date of collection 30-Mar-14 20-Jun-2014
Wavelength (Å) 1.0000 0.872600
Spacegroup P4 I4
a, b, c (Å) 87.439, 87.439, 79.468 87.202 87.202 142.337
α, β, γ (°) 90.00, 90.00 90.00 90.00 90.00 90.00
Resolution limits (Å) 48.80–2.58 (2.72–2.58) 46.61–2.55 (2.68–2.55)
Rmerge (%) 4.7 (75.0) 6.8 (71.5)
<I/σ> 15.1 (1.6) 10.6 (1.5)
Multiplicity 3.4 (3.1) 3.2 (3.1)
Completeness (%) 99.1 (96.6) 99.7 (99.9)
Total number of reflections 63119 (8153) 54301 (7759)
Number unique reflections 18751 (2635) 17256 (2522)
Refinement and model
statistics
Rwork (%) 26.0 19.8
Rfree (%) 30.0 25.4
Rmsd bond distance (Å) 0.0034 0.002
Rmsd bond angle (°) 0.761 0.704
Ramachandran analysis
Outliers (%) 0 0.3
Favored (%) 92.0 96.1
Average B-factors
Chain A 91.1 74.4




Structure of the SthK C-Linker/CNBD in Complex with cAMP or cGMP
PLOSONE | DOI:10.1371/journal.pone.0116369 January 27, 2015 5 / 12
Next, we investigated whether the molecular determinants for cAMP and cGMP recogni-
tion are conserved between SthK and eukaryote HCN channels. Similar to HCN channels, the
cAMP molecule is located in a binding cavity that is formed by the β-roll and C-helix from the
CNBD of SthK-Cterm (Fig. 3a-b). The phosphoribose group from cAMP is buried into this
binding cavity whereas the adenosine ring is pointing towards the opening of the binding cavi-
ty. Similar as in the previously shown mouse HCN2 and sea urchin SPIH structures, the cAMP
molecule is bound in an anti-conformation. Besides the overall similar orientation of cAMP in
the CNBD from SthK-Cterm, the individual protein-ligand interactions also seem to be very
well conserved between the prokaryote SthK CNBD and the eukaryote CNBD from HCN2 and
SPIH. The interaction blueprint around the phosphoribose group from cAMP with SthK-Cterm
looks almost identical to the one shown for HCN2 (Fig. 3a-b). The phosphoribose from cAMP
interacts with residues Gly-367, Glu-368, Arg-377 and Thr-378 (resp. Gly-581, Glu-582, Arg-
591 and Thr-592 in HCN2 and Gly-610, Glu-611, Arg-620 and Val-621 in SPIH). In HCN2,
Ile-583 and Cys-584 are also lining the binding cavity around the phosphoribose group but
these residues are not conserved in the SthK CNBD (Met-369 and Ala-370, resp.). However,
Fig 1. Molecular architecture of the SthK C-terminal domain. a) Superposition of the SthK-Cterm tetramer onto the open gate structure of the Kv1.2
channel. The CNBD is shown in blue, the C-linker in green and the transmembrane domain in yellow. Only two transmembrane subunits are shown for clarity.
b)Cartoon representation of a single SthK-Cterm monomer. The C-linker is shown in red, the β-roll in blue and the C-helix in green. The cAMPmolecule is
shown in sphere representation. Blue atoms are nitrogen, white atoms are carbon and red atoms are oxygen. c) Top down cartoon view of the SthK-Cterm
tetramer along the fourfold symmetry axis. Each of the four subunits is shown in a different color. d) Superposition of the C-linker of SthK (yellow) onto HCN2
(white). e) Superposition of the CNBD of SthK (yellow) onto HCN2 (white)
doi:10.1371/journal.pone.0116369.g001
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protein-ligand interactions at this location appear to be established mainly by backbone inter-
actions and therefore Met-369 and Ala-370 in SthK are able to accomplish the same ligand in-
teractions. Furthermore, protein-ligand interactions are also conserved around the purine ring
from cAMP. Arg-632 from HCN2, which has been shown to play an important role in ligand
binding through interaction with N6 via a hydrogen bound, is clearly conserved in the SthK
CNBD (Arg-418). In that same region we could also see that other key residues such as Val-
348 and Leu-361 (Val-564 & Leu-574 in HCN2 and Ile-592 & Leu-603 in SPIH) are also con-
served in the SthK CNBD. Additionally, it is known that HCN2 and SPIH line the binding cav-
ity near the purine ring with polar residues, Met-572 and Thr-601, respectively. The CNBD
from SthK has an alanine (Ala-358) located at this position. However, lack of interaction be-
tween this Ala-358 and N6 from cAMP appears to be compensated by the presence of Glu-421
in SthK-Cterm, which forms a strong hydrogen bound with N6. All together, analysis of the in-
teractions in the binding pocket shows that the cAMP molecule binds in a similar way as
shown for HCN2 and SPIH. This result confirms that the molecular determinants for ligand
recognition are highly conserved in SthK-Cterm, despite the distant evolutionary relationship
between SthK and eukaryote HCN channels. In the structure of cGMP-bound SthK-Cterm we
observe that cGMP is able to bind in the cyclic nucleotide binding cavity from SthK (Fig. 3c).
Fig 2. The SthK-Cterm structure in complex with the agonist cAMP is in a more open conformation than in the complex with the antagonist cGMP.
a) Top down cartoon view of the SthK-Cterm structure in complex with cGMP is shown in blue b) Same view as in a) for SthK-Cterm in complex with cAMP,
shown in red. The yellow spheres indicate the position where the C-linker starts and is also the site where the C-linker connects to the gate of the channel. c)
Differences in monomer conformation after superposition of the cAMP-bound tetramer onto the cGMP-bound tetramer. Blue is cGMP-bound, red is cAMP-
bound. d) Side view of SthK-Cterm in complex with cGMPwith one subunit omitted for clarity. e) same view as in d) but for SthK-Cterm in complex with cAMP.
doi:10.1371/journal.pone.0116369.g002
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Moreover, the phosphoribose group from cGMP establishes the same interactions that were
described earlier for the phosphoribose group from cAMP in the SthK-Cterm structure. Re-
markably, we observe that cGMP is bound in its anti-conformation in SthK-Cterm whereas pre-
viously published cGMP-bound CNBD structures showed the cGMP molecule bound in its
syn conformation (Fig. 3d) [9, 12]. The anti-conformation in the cGMP-bound SthK-Cterm
structure prevents the purine ring of cGMP from establishing binding interactions with the
Fig 3. Molecular determinants of ligand recognition in the SthK-Cterm in complex with cAMP or cGMP. a-b)Comparison of the amino acids in the
ligand binding site involved in recognition of cAMP in SthK (left) and HCN2 (right). Amino acids of the β-roll are shown in blue sticks, residues of the C-helix in
green sticks. The C-helix is shown in cartoon representation. The cAMPmolecule is shown in yellow. Dashed lines represent hydrogen bonds or salt bridges.
c-d) Comparison of the cGMP bound SthK-Cterm with the cGMP bound structure of HCN2 illustrates that the cGMPmolecule binds in the anti-conformation,
whereas previously published structures showed cGMP bound in its syn-conformation. Locked in the anti-conformation, the phosphoribose part of cGMP is
able to establish the same interaction with SthK-CNBD as cAMP. However, the anti-conformation appears to inhibit interactions between the purine ring from
cGMP and the C-helix from the SthK-CNBD. Most likely, the absence of these interactions explains why binding of cGMP to SthK does not provide the
required energy for the opening conformational changes.
doi:10.1371/journal.pone.0116369.g003
Structure of the SthK C-Linker/CNBD in Complex with cAMP or cGMP
PLOSONE | DOI:10.1371/journal.pone.0116369 January 27, 2015 8 / 12
C-helix or Thr-378 from the CNBD (Fig. 3c-d) [12]. Therefore, it is possible that antagonism
by cGMP arises from missing interactions between the purine ring of cGMP and the C-helix of
SthK.
DISCUSSION
Our results support a molecular mechanism in which agonist binding to the C-linker/CNBD
results in channel modulation via allosteric conformational changes which involve movement
of the C-helix relative to the β-roll together with a global upward and outward movement of
the C-linker/CNBD. These results thereby extend on previous insight derived from studies in-
vestigating the dynamic properties of the C-linker/CNBD using various techniques. First, disul-
fide cross-linking studies between introduced cysteines in the C-helix demonstrated that
disulfide bridge formation primarily occurred in closed channels and inhibited channel activa-
tion. This result indicated that the C-helices are in close proximity in the closed state and move
apart during channel opening [24, 25]. Furthermore, the role of C-helix movement towards the
β-roll has been proposed based on various mutagenesis studies on the CNGA1 channel. One of
these studies showed that substitution of residue D604 in the CNGA1 C-helix has major effects
on the allosteric transitions of the C-linker-CNBD [26]. The role of the C-helix movement was
further demonstrated using the substituted cysteine accessibility method (SCAM) in which
modulation of a specific residue in the C-helix of CNGA1, G597C, prevented the allosteric
transitions that are required for channel opening even though the G597C modulation did not
appear to interfere with initial ligand binding to the C-linker/CNBD [27]. Based on mutagene-
sis studies by Flynn et. al (2007) on the cyclic nucleotide modulated channel SpIH, a modula-
tion mechanism was suggested in which the β-roll interactions were thought to play an
important role in cyclic nucleotide binding affinity whereas interactions with the C-helix were
described to be involved in efficiency of the allosteric transitions. In addition, using transition
metal ion FRET it was demonstrated that agonist binding causes a stabilization of the C-helix
in HCN2 [16, 28]. Additional evidence supporting an important dynamic role of the C-helix
comes from X-ray crystal structures and NMR structures of the MlotiK1 CNBD. X-ray crystal-
lography revealed 6 distinct conformations of the C-helix in MlotiK1, making it difficult to
infer how the C-linker moves during channel gating [29]. NMR spectroscopy was employed to
determine structures of the MlotiK1 CNBD in absence and presence of cAMP and demonstrat-
ed a movement of the A-, B- and C-helices with respect to the β-roll [30, 31]. Finally, a recent
study employed double electron-electron resonance (DEER) spectroscopy and found motions
up to 10 Å induced by cAMP binding in HCN2. The data further indicate a reorientation of
several helices within the CNBD, including the C-helix [23].
Our results provide structural insight into the differences between the agonist and antago-
nist bound state of C-linker/CNBD from SthK. The structure of SthK-Cterm in complex with
cAMP, which is an agonist, reveals extensive ligand interactions with the β-roll and the C-helix
from SthK-Cterm which are similar to interactions that have been previously described for the
cAMP bound HCN2 C-terminal structures. However, superposition of the cAMP bound
HCN2 structure and the cAMP-bound SthK-Cterm structure shows a prominent outward and
upward shift at the aminoterminal end of the C-linker from the SthK-Cterm, which connects to
the S6 segment of the transmembrane channel pore. This shift results in a greater distance
(28.6Å) at the C-linker tetramer interface of SthK which mirrors the carboxyterminal residues
of the S6 segment from the open gate structures of the Kv1.2 channel [18] (29.7Å) or the MthK
channel [18, 19] (30.3Å). This result suggests that the SthK structure may represent an activat-
ed or intermediate conformation, whereas previously published HCN structures have been
suggested to represent an intermediate [9] or resting [32] conformation. Additionally, the
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structure of SthK-Cterm in complex with cGMP, which is an antagonist, shows the SthK-Cterm
in a more closed conformation which is similar to the conformations which were previously
shown for HCN2 C-terminal structures. Besides the conformational changes between SthK-
Cterm in complex with cGMP and cAMP, the structure of SthK-Cterm in complex with cGMP
also provides structural insights into antagonist binding in the C-linker/CNBD. In contrast to
previously published HCN structures which showed the cGMP molecule bound in its syn-con-
formation [9, 12], the crystal structure of SthK-Cterm shows a cGMP molecule bound in the
anti-conformation. We observe that this conformation disables cGMP to establish the interac-
tions with the C-helix as were found in the cAMP bound SthK-Cterm and the cAMP and
cGMP bound HCN2 structures. Therefore, this differential orientation might explain why
cGMP acts as an agonist in HCN2 channels but as an antagonist in the SthK channel. More-
over, the SthK-Cterm crystal structure suggests that binding of the cGMP molecule in the syn
conformation might be prevented by the presence of the Leu-422 residue which enters the
cGMP binding pocket and is equivalent to the Asp residue which has been described to play an
important role in cGMP specificity [14, 26].
Together, the SthK crystal structures offer a framework for understanding conformational
changes during ligand activation of cyclic nucleotide-modulated ion channels. We suggest a
molecular mechanism of channel modulation in which binding of a cAMP molecule causes an
outward swinging motion of the P-helix, together with the B- and C-helices of the CNBD. This
movement is then transmitted through the D’-E’-F’-helices of the C-linker, which remain rela-
tively constant. The outward movement of the C’-helix together with a pronounced bending of
the A’-helix then creates a force to open the channel gate. Such a model for channel modulation
is compatible with a previously suggested mechanism in which the CNBD imposes an inhibito-
ry effect on the channel gate and ligand binding causes a relief of inhibition [33]. We suggest
that the insight derived from the SthK-Cterm crystal structures possibly extends to other cyclic
nucleotide-modulated channels, including HCN and CNG channels. This work paves the way
for crystallization efforts of the full-length SthK channel as well as further biochemical and
spectroscopic studies, including NMR and DEER spectroscopy.
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